References
Arcas J, Ferrer T, Roche MC et al. Hypohidrosis related to the administration of topiramate to children. Epilepsia 2001; 42: 1363–1365.
Ben Zeev B, Watemberg N, Augarten A et al. Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect. J Child Neurol 2003; 18: 254–257.
de Carolis P, Magnifico F, Pierangeli G et al. Transient hypohidrosis induced by topiramate. Epilepsia 2003; 44: 974–976.
Ziad eK, Rahi AC, Hamdan SA et al. Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia. Neurology 2005, 65: 1139–1140.
Cerminara C, Seri S, Bombardieri R et al. Hypohidrosis during topiramate treatment: a rare and reversible side effect. Pediatr Neurol 2006; 34: 392–394.
Galicia SC, Lewis SL, Metman LV. Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction. Clin Neuropharmacol 2005; 28: 94–95.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fung, E.L.W., Nelson, E.A.S. Oligohydrosis underestimated side effect with topiramate treatment. Indian J Pediatr 74, 694 (2007). https://doi.org/10.1007/s12098-007-0124-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-007-0124-9